{"id":"W4255942265","doi":"10.1158/1538-7445.sabcs18-ct139","title":"Abstract CT139: NCI Molecular Analysis for Therapy Choice (NCI-MATCH EAY131) arm B: Phase II study of afatinib in patients (pts) with HER2 (ERBB2) activating mutations","year":2019,"lang":"en","type":"article","venue":"Clinical Trials","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Afatinib; Medicine; Oncology; Internal medicine; Cancer; Epidermal growth factor receptor; Erlotinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.008005743,0.0002747003,0.002214826,0.0003527813,0.00008285139,0.00003294668,0.0002732399,0.0002334923,0.0004598676],"category_scores_gemma":[0.0160316,0.0001981979,0.0005946409,0.00105401,0.0001121725,0.0001425824,0.00007656372,0.0004329596,0.00001732088],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009733287,"about_ca_system_score_gemma":0.001864653,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006439245,"about_ca_topic_score_gemma":0.00008857743,"domain_scores_codex":[0.9943546,0.000737966,0.002796825,0.0007239471,0.0009530207,0.0004336475],"domain_scores_gemma":[0.9848024,0.01231739,0.001145489,0.000917265,0.0005751224,0.0002423356],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.05644432,0.1044088,0.5891706,0.0006733554,0.01789939,0.0001117904,0.004662275,0.005626495,0.00727882,0.00006478823,0.00024786,0.2134115],"study_design_scores_gemma":[0.6921658,0.05360559,0.2332295,0.0004713634,0.001980519,0.00000174291,0.002411378,0.007153044,0.007569605,0.0001362757,0.0006575296,0.0006176588],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931142,0.00005285389,0.0001599826,0.0001387403,0.0001253839,0.006027796,0.00004014419,0.00003487682,0.0003060039],"genre_scores_gemma":[0.9984934,0.00001884093,0.0006552314,0.0001364332,0.0001636285,0.0002329053,0.0001070548,0.00005274757,0.0001397049],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6357214,"threshold_uncertainty_score":0.9922568,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2292891931188603,"score_gpt":0.5331464358580582,"score_spread":0.3038572427391979,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}